EDUCATION
FAQ
News
Newsletter
HRP Training
Resources – Guidebook
Webinars
Guidance Documents
CONTACT
Main Contact
Directions & Accommodations
Customer Satisfaction Survey
Send email via website
LOGIN
SEARCH
Tel: 954.327.0778 | Fax: 954.327.5778 | E-mail:
info@iirb.com
History
Mission Statement
Compliance
Accreditation
FDA Audit
Getting Started
Services
EPA
Your IRB of Choice
Our Services
Forms
IRB Roster, Fees & Calendar
HRP Training
Your IRB of Choice
Our Services
Forms
IRB Roster, Fees & Calendar
HRP Training
Resources
Role of IIRB
Before you say “Yes”
If you say “Yes”
Key Terms
Resources
“Providing guidance to clients for over 20 years!”
FAQ
|
News
|
Newsletter
|
HRP Training
|
Resources - Guidebook
|
Webinars
|
Guidance Documents
Guidance Documents
The Independent IRB, Inc. has developed the following guidance documents to provide assistance in various components of research as they relate to the IRB review and the submission process.
The Database Management Issues Non-Covered Entities
(new)
The Database Management Issues Non-Covered Entities guidance document is intended to provide assistance in developing a written Database Management Plan that encompasses adequate measures to protect the privacy of research participant and the confidentiality of their data.
The Infectious Disease Testing in Research Studies
The Infectious Disease Testing in Research Studies document is intended to provide information about the philosophy and recommendations regarding reporting and counseling of infectious diseases, disclosure of testing to research participants, and the use of a separate HIV Informed Consent Form.
Role of Secondary IRB
Role of Secondary IRB document is intended to provide information about the philosophy and recommendations regarding the function of a secondary IRB when Independent IRB, Inc. has full authority and oversight of a research study at an approved Site.
Independent IRB, Inc. HIPAA Policy
The Independent IRB, Inc. HIPAA Policy guidance document is intended to provide clarification to the review and submission process for a “Non-Covered Entity” as related to HIPAA regulations.
Review of Research Involving an IND Pending FDA 30 Day Review
The Review of Research Involving an IND Pending FDA 30 Day Review guidance document is intended to provide information regarding the review and submission process for research studies with an IND pending FDA 30 day review and includes approval and screening options in such circumstances.
The guidance documents are consistent with the Independent IRB, Inc. Human Research Protection Program Plan (HRPP Plan) and in no way supersedes the requirements contained in the HRPP Plan. Please note the Independent IRB, Inc. can revise these guidance documents at any time it is necessary to comply with regulatory requirements.